The results showed that the sum of the CD8+ and CD4+ percentages was related to the postoperative survival of patients, which may be related to the immune effect of CD8+; the higher the CD8+ CD4+ value is, the stronger the immune effect of the tumor, and the higher the SR. The gene discussed is CD8A; the disease is neoplasm.